Welch & Forbes’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Welch & Forbes’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-221,582	Closed	-$7.81M	–	339
2015 Q1	$7.81M	Sell	221,582 -13,806	-6%	-$467K	0.23%	103
2014 Q4	$7.56M	Sell	235,388 -8,140	-3%	-$235K	0.22%	109
2014 Q3	$6.83M	Sell	243,528 -8,640	-3%	-$263K	0.21%	108
2014 Q2	$7.62M	Sell	252,168 -800	-0.3%	-$22.1K	0.24%	98
2014 Q1	$7M	Buy	252,968 +358	+0.1%	+$9.37K	0.22%	102
2013 Q4	$6.45M	Sell	252,610 -87,590	-26%	-$2.7M	0.2%	106
2013 Q3	$10.2M	Sell	340,200 -12,930	-4%	-$360K	0.34%	81
2013 Q2	$10.2M	Buy	+353,130	New	+$9.73M	0.36%	78

Other funds holding BRLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Welch & Forbes's BRLI Position: Q2 2015 in Review

Welch & Forbes sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 221,582 shares — an estimated $7.81M sold.

Welch & Forbes first reported a position in BRLI in Q2 2013 and held it in 8 quarters. The position peaked at $10.2M in Q3 2013. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

Welch & Forbes reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
Welch & Forbes sold 221,582 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $7.81M.
Welch & Forbes first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 8 quarters.
Welch & Forbes's BIO-REFERENCE LABS INC-NEW- position peaked at $10.2M in Q3 2013.
183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on Welch & Forbes's 13F filing for Q2 2015, filed 11 Aug 2015.